Polymorphisms of the TNF-α gene and risk of celiac disease in T1DM children

Pediatric Diabetes

Volumn 8, Issue 3, 2007, Pages 138-141

  Hermann, Csaba ^a,d   Krikovszky, Dóra ^b   Vásárhelyi, Barna ^c   Dezsofi, Antal ^b   Madácsy, László ^b  

^a Szent Rokus Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d NONE   (Hungary)

Author keywords

Celiac disease; Genetic polymorphism; Tumor necrosis factor a; Type 1 diabetes mellitus

Indexed keywords

ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; JEJUNUM BIOPSY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ADOLESCENT; AGE OF ONSET; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RISK ASSESSMENT; SEQUENCE DELETION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249864450     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00238.x     Document Type: Article

References (12)

1. Holmes GKT. Coeliac disease and type 1 diabetes mellitus - the case for screening. Diabetes 2001: 18: 169-177.
2. De Vitis I, Ghirlanda G, Gasbarrini G. Prevalence of coeliac disease in type 1 diabetes: A multicentre study. Acta Paediatr Suppl 1996: 412: 56-57.
3. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998: 14: 129-151.
4. O'Keeffe J, Lynch S, Whelan A et al. Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease. Clin Exp Immunol 2001: 125: 376-382.
5. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influance TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998: 113: 401-406.
6. Cox A, Gonzalez AM, Wilson AG et al. Comparative analysis of the genetic association of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia 1994: 37: 500-503.
7. de la Concha EG, Fernandez-Arquero M, Vigil P et al. Coeliac disease and TNF promoter polymorphisms. Hum Immunol 2000: 61: 513-517.
8. Kaijzel EL, van Krugten MV, Brinkman BM et al. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998: 4: 724-733.
9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleaed cells. Nucleic Acids Res 1988: 16: 1215.
10. Szalai C, FüSt G, Duba J et al. Association of polymorphism and allelic combinations in the tumour necrosis factor-α-complement MHC region with coronary artery disease. J Med Genet 2002: 39: 46-51.
11. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Bruschenefelde KH, Rittner C. Atumour necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998: 111: 579-582.
12. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer Zum Bruschenefelde KH, Rittner C. Tumour necrosis factor-alpha promoter polymorphism at position - 238 is associated with chronic active hepatitis C infection. J Med Virol 1998: 54: 173-177.